SCHEMBL24046151

SCHEMBL24046151

CCCCOc1ccc(-c2cc3ccc(OC(C)(C)C)cc3oc2=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.56
TP53 P04637 2/20 0.54
NPC1 O15118 9/20 0.52
RAB9A P51151 9/20 0.52
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA3 P07451 1/20 0.51
CA4 P22748 1/20 0.51
CA6 P23280 1/20 0.51
CA7 P43166 1/20 0.51
CA9 Q16790 1/20 0.51
CA14 Q9ULX7 1/20 0.51
CA5B Q9Y2D0 1/20 0.51
KDM4E B2RXH2 4/20 0.51
GLA P06280 4/20 0.51
ALDH1A1 P00352 3/20 0.51
GAA P10253 3/20 0.51
HPGD P15428 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24046282 0.87 MAOB (0.69) MAOBTP53NPC1RAB9ACA12
SCHEMBL18535597 0.87 MAOB (0.62) MAOBTP53NPC1RAB9ACA12
SCHEMBL18535513 0.86 MAOB (0.61) MAOBTP53NPC1RAB9ACA12
SCHEMBL22625283 0.84 MAOB (0.58) MAOBTP53NPC1RAB9ACA12
SCHEMBL2167401 0.83 MIF (0.71) MAOBTP53NPC1RAB9AKDM4E
SCHEMBL23713537 0.83 MAOB (0.58) MAOBTP53NPC1RAB9ACA12
SCHEMBL18535458 0.83 NPC1 (0.71) MAOBTP53NPC1RAB9ACA12
SCHEMBL23713486 0.82 TP53 (0.58) MAOBTP53NPC1RAB9ACA12
SCHEMBL6689326 0.82 TP53 (0.74) MAOBTP53NPC1RAB9AKDM4E
SCHEMBL23713470 0.81 MIF (0.68) MAOBTP53NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210363122-A1 COMPOUNDS FOR OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2021-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210363122-A1 COMPOUNDS FOR OPTICALLY ACTIVE DEVICES PDE6C, ALDH1A2, PDE6A MAOB 212/4885TP53 4837/4885NPC1 2482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.